U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H9NO
Molecular Weight 87.1204
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTANAMIDE

SMILES

CCCC(N)=O

InChI

InChIKey=DNSISZSEWVHGLH-UHFFFAOYSA-N
InChI=1S/C4H9NO/c1-2-3-4(5)6/h2-3H2,1H3,(H2,5,6)

HIDE SMILES / InChI

Molecular Formula C4H9NO
Molecular Weight 87.1204
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
1-(4-Bromo-phen-yl)-3-butano-ylthio-urea.
2010-12-08
Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies.
2010-12-06
Synthesis of the sponge-derived plakortone series of bioactive compounds.
2010-10-01
Dimeric supramolecular motifs of two carboxylate-guanidinium compounds.
2010-09
Direct assay of delta-aminolevulinic acid dehydratase in heme biosynthesis for the detection of porphyrias by tandem mass spectrometry.
2010-08-01
A new acylamidase from Rhodococcus erythropolis TA37 can hydrolyze N-substituted amides.
2010-08
Structure-activity relationships of 33 carboxamides as toxicants against female Aedes aegypti (Diptera: Culicidae).
2010-03
4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
2010-02
Sensitive and specific enzyme immunoassays for antigenic trisaccharide from Bacillus anthracis spores.
2009-12-21
N-(3,4-Dichloro-phen-yl)-3-oxo-butanamide.
2009-12-04
An analytic potential energy function for the amide-amide and amide-water intermolecular hydrogen bonds in peptides.
2009-11-30
Effect of the regiochemistry of butyl amide substituents on the solution-state structures of lanthanide(III) DOTA-tetraamide complexes.
2009-11-02
Synthesis, cytotoxicity by bioluminescence inhibition, antibacterial and antifungal activity of ([1,2,4]Triazolo[1,5-c]quinazolin-2-ylthio)carboxylic acid amides.
2009-11
Advances in marine microbial symbionts in the china sea and related pharmaceutical metabolites.
2009-04-20
2-(4-Chloro-phen-yl)-3-methyl-N-(5-methyl-thia-zol-2-yl)butanamide.
2008-12-20
Aluminum-catalyzed asymmetric alkylations of pyridyl-substituted alkynyl ketones with dialkylzinc reagents.
2008-07-30
Chili pepper fruits: presumed precursors of fatty acids characteristic for capsaicinoids.
2008-06-11
Functional human 5-HT6 receptor assay for high throughput screening of chemical ligands and binding proteins.
2008-05
R-stereoselective amidase from Rhodococcus erythropolis No. 7 acting on 4-chloro-3-hydroxybutyramide.
2008-03
N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
2008-01
Selective androgen receptor modulators in preclinical and clinical development.
2008
Synthesis of DL-fluorobenzenamides as anticonvulsants.
2008
[Preprocessing of collagenous sources with the aim of extracting minimally denatured collagen].
2007-11-07
Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents.
2007-08-23
Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
2007-07-07
Total solid-phase synthesis of bombesin analogs with different functional groups at the C-terminus.
2007-07
Comparative transport efficiencies of urea analogues through urea transporter UT-B.
2007-07
Reduction of site-specific CYP3A-mediated metabolism for dual angiotensin and endothelin receptor antagonists in various in vitro systems and in cynomolgus monkeys.
2007-05
3-[2-((2S)-2-cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes.
2007-03-01
Bioconversion of butyronitrile to butyramide using whole cells of Rhodococcus rhodochrous PA-34.
2007-03
[State of intracellular signaling systems in endothelial dysfunction].
2007
Future therapeutic treatment of COPD: struggle between oxidants and cytokines.
2007
Gastroprotective activity and cytotoxic effect of cyperenoic acid derivatives.
2006-11
4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties.
2006-09-15
Involvement of basal protein kinase C and extracellular signal-regulated kinase 1/2 activities in constitutive internalization of AMPA receptors in cerebellar Purkinje cells.
2006-05-03
Distributed polarizabilities obtained using a constrained density-fitting algorithm.
2006-01-14
Solvent friction effect on intramolecular electron transfer.
2005-12-21
Synthesis of uniform protein-polymer conjugates.
2005-11-15
Application of Fourier transform infrared spectroscopy for monitoring hydrolysis and synthesis reactions catalyzed by a recombinant amidase.
2005-11-01
Activity coefficients and thermodynamic parameters for RbCl/CsCl + amide (acetamide, propanamide, and n-butanamide) + water system at 298.15 K.
2005-10-22
Transferable potentials for phase equilibria. 7. Primary, secondary, and tertiary amines, nitroalkanes and nitrobenzene, nitriles, amides, pyridine, and pyrimidine.
2005-10-13
Identification of dielectric and structural relaxations in glass-forming secondary amides.
2005-08-01
Purification and characterization of a serine alkaline protease from Bacillus clausii GMBAE 42.
2005-08
Amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid as modified orally active estrogen agonists with moderate antagonistic activity.
2005-01-03
Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage.
2004-11-26
Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
2004-08-12
Sterically and guest-controlled self-assembly of calix[4]arene derivatives.
2004-05-03
4-Substituted anilides as selective melatonin MT2 receptor agonists.
2004-02-23
General pharmacology of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
2003
Synthesis of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
2003
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 19:24:59 GMT 2025
Edited
by admin
on Mon Mar 31 19:24:59 GMT 2025
Record UNII
9J6OR937VR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUTANAMIDE
Systematic Name English
N-BUTYRAMIDE
MI  
Preferred Name English
BUTYRAMIDE
FHFI  
Systematic Name English
N-BUTYLAMIDE
HSDB  
Systematic Name English
BUTYRAMIDE [FHFI]
Common Name English
NSC-8424
Code English
N-BUTYLAMIDE [HSDB]
Common Name English
BUTANOIC ACID, AMIDE
Common Name English
BUTANIMIDIC ACID
Systematic Name English
FEMA NO. 4252
Code English
N-BUTYRAMIDE [MI]
Common Name English
Classification Tree Code System Code
JECFA EVALUATION BUTYRAMIDE
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
Code System Code Type Description
MESH
C006866
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
CHEBI
50724
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
PUBCHEM
10927
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
DRUG BANK
DB02121
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
RXCUI
1653515
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY RxNorm
WIKIPEDIA
BUTYRAMIDE
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
JECFA MONOGRAPH
1582
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
ECHA (EC/EINECS)
208-776-4
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
MERCK INDEX
m2866
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY Merck Index
NSC
8424
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
HSDB
5684
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
CAS
541-35-5
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
SMS_ID
100000163191
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
EVMPD
SUB177334
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
FDA UNII
9J6OR937VR
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY
EPA CompTox
DTXSID8060248
Created by admin on Mon Mar 31 19:24:59 GMT 2025 , Edited by admin on Mon Mar 31 19:24:59 GMT 2025
PRIMARY